- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03925363
A Mobile Application to Increase Physical Activity
A Mobile Application to Increase Physical Activity, a Randomized Controlled Study
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
In this randomized controlled study, it will be tested if a mobile application can increase physical activity and reduce the risk of later non-communicable disease.
Participants include individuals that previously have been included in a health survey (Healthy aging initiative, NCT03312439), with a low registered physical activity. Low physical is defined according to WHOs definition, i.e. at least 150 minutes of physical activity per week. Individuals will diabetes will be investigated separately.
Individuals will be excluded that cannot walk for exercise, or if they have diseases that severely affects the ability to exercise. We will also seek participants from the general population to be included with only two inclusion criteria; having a smart phone and at least 18 years of age.
Participants the meet the inclusion criteria will be randomized to an application that only registers physical activity (blind-app) or an application where the participants will set appropriate goals for physical activity and get proper feedback from the app when these goals are reached (feedback-app). Both groups will have individualized information about proper physical activity. Randomization will be made using sealed envelopes in permuted blocks of 10. Randomization will be stratified on year of birth and sex.
The primary outcome will be increased physical activity after 6 months. Secondary outcomes include cardiovascular disease, death, dementia, falls and fractures, diabetes, and improved glucose control in those that already have diabetes. Secondary outcomes also include changes in cardiovascular risk factors, such as blood pressure, blood lipids and obesity. Interaction analysis will be performed to investigate if the effects are different in men and women, based on baseline physical activity and based on age.
Based on the results from the previous health survey the individuals have participated in, a power analyses has been conducted. The participants physical activity were registered using accelerometers. The mean steps taken per week was 48000 with a standard deviation of 22000 steps. With assumption that the feedback-app will increase physical activity by at least 15%, 164 individuals would be needed in each group with an alpha level of 0.05 and a power of 80%. For secondary outcome of cardiovascular disease or death, estimates were based on incidence of these outcomes in 3617 individuals that participated in the health survey. During a mean follow up time of 928 days, 221 participants was diagnosed with cardiovascular disease or died during follow up, and 128 were diagnosed with cardiovascular disease. If assuming that the mobil-application will result in 15% lower risk of these two outcomes in those randomized to the feedback-app, 597 and 1371 individuals would be needed in each group, respectively, with the same follow up time. The effects during follow up will be monitored each year of follow up through patient registers. Follow up time is scheduled to a maximum of 2 years. We estimate that we then would need 895 and 2156 individuals in each group due to the shorter follow up time compared to in the example above.
Typ studie
Zápis (Očekávaný)
Fáze
- Nelze použít
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Previous participants in healthy aging initiative.
Exclusion Criteria:
- Not able to walk or previous medical diagnoses that severely limits the possibility to exercise.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Trojnásobný
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Active
Participants will be given a mobile-app where they will get feedback from the device based on their physical activity (feedback app)
|
The active group will be given the feedback app and the control group the blind app
|
|
Falešný srovnávač: Control
Participants will be given a mobile-app that does not give feedback back, but the app will register physical activity (blind app).
|
The active group will be given the feedback app and the control group the blind app
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Increased physical activity as measured by the mobile application in steps per day
Časové okno: 3 years (anticipated)
|
Increased physical activity in steps per day during the intervention period.
|
3 years (anticipated)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Incidence of myocardial infarction
Časové okno: 3 years
|
Diagnoses of myocardial infarction will be tracked using national registers.
|
3 years
|
|
Incidence of diagnosed diabetes
Časové okno: 3 years
|
Diabetes diagnoses or start of treatment for diabetes will be tracked using national registers.
|
3 years
|
|
Incidence of diagnosed fractures
Časové okno: 3 years
|
Diagnosed fractures will be tracked using national registers.
|
3 years
|
|
Incidence of diagnosed dementia
Časové okno: 3 years
|
Diagnosed dementia or start of treatment using dementia drugs will be tracked using national registers.
|
3 years
|
|
Number of participants with high blood pressure
Časové okno: 1 year (anticipated)
|
Systolic and diastolic blood pressure will be assessed at baseline and later using a sphygmomanometer.
|
1 year (anticipated)
|
|
Number of participants with high blood lipids
Časové okno: 1 year (anticipated)
|
Blood lipids (cholesterol, LDL-cholesterol, and triglycerides) will be analyzed at baseline and after 6 and 12 months at the department of chemistry.
|
1 year (anticipated)
|
|
Number of participants with high blood glucose
Časové okno: 1 year (anticipated)
|
Blood glucose will be analysed at the departement of clinical chemistry at baseline and follow up.
|
1 year (anticipated)
|
|
Grade of obesity
Časové okno: 1 year (anticipated)
|
Obesity will be assessed using a non-elastic measurement tape at the waist
|
1 year (anticipated)
|
|
Body weight
Časové okno: 1 year (anticipated)
|
Body weight in kilogram measured by a digital scale.
|
1 year (anticipated)
|
|
Incidence of stroke
Časové okno: 3 years
|
Diagnoses of stroke will be tracked using national registers.
|
3 years
|
|
Incidence of angina pectoris
Časové okno: 3 years
|
Diagnoses of angina pectoris will be tracked using national registers.
|
3 years
|
|
Incident mortality
Časové okno: 3 years
|
Death during follow up will be tracked using national registers.
|
3 years
|
|
Number of participants with high glycated hemoglobin
Časové okno: 1 year (anticipated)
|
Glycated hemoglobin will be measured at baseline and follow up at the Department of clinical chemistry
|
1 year (anticipated)
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Očekávaný)
Primární dokončení (Očekávaný)
Dokončení studie (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- VCC_LIFE-5
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .